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The past decade has witnessed remarkable advances in our understanding of aquaporin (AQP) structure and function. Much, however, remains
to be learned regarding how these unique and vitally important molecules are generated in living cells. A major obstacle in this respect is that AQP
biogenesis takes place in a highly specialized and relatively inaccessible environment formed by the ribosome, the Sec61 translocon and the ER
membrane. This review will contrast the folding pathways of two AQP family members, AQP1 and AQP4, and attempt to explain how six TM
helices can be oriented across and integrated into the ER membrane in the context of current (and somewhat conflicting) translocon models. These
studies indicate that AQP biogenesis is intimately linked to translocon function and that the ribosome and translocon form a highly dynamic
molecular machine that both interprets and is controlled by specific information encoded within the nascent AQP polypeptide. AQP biogenesis
thus has wide ranging implications for mechanisms of translocon function and general membrane protein folding pathways.
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Fig. 1. Aquaporin structure. (A) Transmembrane topology of AQP1 showing
relative orientation of N- and C-termini, TM segments, and half helices. Two
“half helices” dip partially into the membrane, and their N-termini comprise the
canonical NPA motifs necessary for water permeation. Both N- and C-termini of
native AQPs reside in the cytosol. (B) 3D arrangement of TMs based on crystal
structure of Sui et al. [13]. Note that N- and C-terminal half helices are partially
aligned along their major axis and together form an integral part of the outer ring
of the water-conducting pore.
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Recent advances in aquaporin structure and function have
fundamentally changed our views of how water is transported
across biological membranes. Cloning and characterization of
the first definitive water channel [1,2], CHIP28 (Aquaporin 1),
confirmed early studies regarding the proteinaceous nature of
the transporter [3–5] and initiated the birth of a rapidly
expanding field that has touched broad aspects of biology. It is
now clear that water channels are widely expressed throughout
prokaryotic and eukaryotic kingdoms, and that they play a
major role in normal human physiology and disease [6–8].
Initial insight into the selective basis of water transport provided
by Cryo-EM studies [9–11] has been refined by high resolution
crystal structures to reveal the mechanism of water and glycerol
selectivity at a molecular level [12–15]. With the rapid
maturation of this field, new challenges and questions have
emerged. For example, much remains to be learned about the
precise role of aquaporin expression, regulation, and intra-
cellular trafficking in disease states. Details of AQP structure
have also highlighted a particularly perplexing question.
Namely, how are functional AQP molecules generated in
living cells? This question has specific relevance because
inherited mutations in AQP2 cause nephrogenic diabetes
insipidus [16,17] by disrupting early biogenesis events and
thereby generating unstable structures that are recognized and
degraded by cellular quality control machinery [18–20].
Currently, we have only a rudimentary understanding of
normal AQP folding pathways and virtually no idea how
these pathways are corrupted by disease-related mutations.
This review will therefore attempt to summarize our current
understanding of AQP biogenesis and provide insight into
this particularly challenging aspect of aquaporin biology.
2. Role of the translocon in aquaporin biogenesis
2.1. Aquaporin structure
Aquaporins comprise a ubiquitous family of proteins that
contain six transmembrane segments (TMs) arranged in an
inverse two-fold pseudo-symmetry around a central water-
conducting pore [21,22]. While AQPs generally exhibit a
tetrameric quaternary structure [23], each monomer possesses
an independent water-conducting channel. Early topologic
studies demonstrated that AQP N- and C-termini reside in the
cytosol [24–26], and TMs are connected by two relatively short
intracellular loops (ICL1, 2) and three extracellular loops
(ECL1, 2, 3, Fig. 1A). ICL1 and ECL3 each contains a
canonical NPA motif (β-turn) and a half-helix that partially
cross the membrane and provide key residues for water and
glycerol selectivity [12,13,21]. Thus, the majority of mamma-
lian aquaporin protein is deeply imbedded within the plane of
the lipid bilayer, while the remainder is located in either
cytosolic or extracytosolic environments (Fig. 1B). The
hydrophobic nature of AQPs and their elaborate transmembrane
architecture therefore requires a precise mechanism for
localizing peptide regions into multiple cellular compartmentsas well as efficient folding and packing of TMs within the
membrane.
2.2. General models of translocon structure and function
Like most eukaryotic polytopic proteins, AQP biogenesis is
facilitated by highly specialized folding machinery in the
endoplasmic reticulum (ER) [27,28]. A central component of
this machinery is the Sec61 translocon [29,30], a large ovoid
disc ~100 Å in diameter [31,32] that spans the ER membrane
and serves the principal function of translocating nascent
polypeptide into the ER lumen and integrating TMs into the
lipid bilayer. The translocation channel itself is comprised at
least in part by the heterotrimeric protein Sec61αβγ [33–35].
Fully assembled translocons contain multiple copies of Sec61
[36], as well as numerous other associated proteins that include
signal peptidase complex (SPC), oligosaccharyltransferase
(OST), TRanslocation Associated Membrane protein (TRAM)
and TRanslocation Associated Protein (TRAP) [27,37–40].
Ribosomes bearing secretory and membrane proteins are
usually targeted to the ER very early during synthesis as signal
recognition particle (SRP) binds a signal sequence at the N-
terminus of the nascent peptide, docks at its ER receptor, and
transfers the entire ribosome nascent chain complex (RNC) to
Sec61α [30,41]. In the case of mammalian AQPs, the first TM
facilitates membrane targeting upon emerging from the
ribosome [26,42] when less than 25% of the protein has been
synthesized. Thus, AQP translocation and membrane integra-
tion are temporally coupled to synthesis of the nascent chain by
the ribosome–translocon complex (RTC). A major challenge
currently facing biologists is to understand how these events are
orchestrated within the context of this large and complex
molecular machine (Fig. 2).
Cryo-EM studies of detergent solubilized RTCs have
indicated that the central axis of the translocon is directly
aligned with the exit tunnel of the 60S ribosomal subunit [43–
45]. This is consistent with crosslinking studies demonstrating
that the nascent polypeptide encounters ER translocation
machinery (Sec61, TRAM) as soon as it emerges from the
ribosome [46–50]. As the signal sequence contacts Sec61, it
initiates translocation by opening a channel within the
Fig. 2. General architecture of the ribosome–translocon complex. (A) Structural
model based on cryo-EM studies of detergent solubilized complexes showing
ribosome (gray) bound to the translocon (blue) at numerous points of contact
(translocon projections). A gap of ~12 Å is apparent between the complexes.
The ~10 Å putative translocon pore (internal dotted cylinder) is proposed to be
gated by a helical plug (not shown) and a central ring of hydrophobic residues
(hydrophobic gasket, gray triangles). (B) Alternate model of the RTC derived
from fluorescence quenching experiments performed on fully assembled and
functionally engaged RTC in native ER membranes. The ribosome is shown
docked onto a translocon containing a large central pore that is permeable to
iodide ions and other aqueous agents. The ribosome exit tunnel and translocon
pore form a continuous aqueous pathway that is inaccessible to the cytosol. This
seal is proposed to be maintained by tight binding of the ribosome to the
translocon [51,52]. During synthesis of cytosolic polypeptide domains, the
ribosome–translocon junction is relaxed, and closure of the translocon pore is
facilitated by the ER lumenal chaperone BiP (blue bar) which is also required for
translocation in yeast [99,100,108,110]. The ribosome and translocon are drawn
to approximate relative scale. A folded monomer of AQP1 is also shown in the
membrane (panel A) for comparison.
978 D. Pitonzo, W.R. Skach / Biochimica et Biophysica Acta 1758 (2006) 976–988translocon to create a continuous gated aqueous translocation
pathway that extends from the ribosome exit tunnel to the ER
lumen [51–53]. Experiments with fusion proteins have
demonstrated that TM1 from both AQP1 and AQP4 efficiently
opens this channel to initiate translocation of the first
extracellular loop [26,42]. While it is generally agreed that
the translocation pathway is lined at least in part by Sec61α
and that Sec61α is one of the first proteins encountered by the
newly synthesized nascent chain, the actual composition and
dimensions of the translocation channel remain controversial.
Crystal structures of a purified, solubilized Sec61 homolog
(SecYEβ) derived from Methanococcus have suggested that
translocation takes place through a relatively small pore (8–
12 Å) formed by a single Sec61 heterotrimer (Fig. 2A) [33]. In
contrast, fluorescence quenching experiments using assembled
and functional translocons in native ER membranes have
indicated that the nascent polypeptide is located within a much
larger pore (∼40 Å) (Fig. 2B) [53]. Further work is therefore
required to define the precise composition and physical
environment of the translocation pathway in functional and
intact translocons.
3. Mechanistic aspects of AQP topogenesis
There are two central questions regarding early aspects of
aquaporin biogenesis. How is AQP topology established across
the ER membrane? And how are AQP TMs inserted, integrated,and subsequently folded within the hydrophobic environment
of the lipid bilayer? Several studies have begun to provide a
mechanistic basis with which to view this process. Because
AQP polypeptide encounters the translocon as it exits from the
ribosome, the translocon must actively direct lumenal and
cytoplasmic loops into their respective cellular compartments
while at the same time ensuring that TMs are correctly inserted
into the lipid bilayer. Moreover, this process occurs rapidly as
the nascent chain is expelled from the ribosome exit tunnel at a
rate of approximately 5-amino-acid residues per second [54,55].
In order for integration to occur in a cotranslational manner (i.e.,
during synthesis), the translocation pathway must be highly
dynamic, tightly controlled, and precisely coordinated with the
synthesis of TM segments and peptide loops. Current evidence
indicates that this process is orchestrated via reciprocal
interactions whereby access of the nascent polypeptide to the
ER lumen, cytosol and lipid bilayer is regulated by the RTC
[27,56]. In turn, the pathway through the RTC is controlled by
specific topogenic information encoded within the nascent
polypeptide [57,58]. For example, topology of extracellular
loops is established as they translocate into the ER lumen
through the open gate of the translocon pore. However, after
synthesis of an ECL, translocation must be terminated in order
to direct the next peptide loop (ICL) into the cytosol. Similarly,
after synthesis of an ICL, the translocation pathway must be re-
opened to allow peptide movement into the ER lumen. Thus,
one would predict that during the cotranslational assembly of
polytopic proteins, specific signals within the nascent protein
should open, close, and re-open the translocation pathway and
thereby provide selective access of intracellular and extracel-
lular loops to the cytosol and ER lumen, respectively [27].
3.1. AQP4 topogenesis
Studies attempting to address how lumenal and cytosolic
access is controlled during AQP biogenesis have examined the
ability of TMs to change the direction of translocation as the
nascent protein is synthesized within the RTC [26,42,59–61]. In
the case of AQP4, TMs 1, 3, and 5 function as signal (anchor)
sequences to efficiently open the translocation pathway and
direct movement of extracellular loops 1, 2, and 3 into the ER
lumen [42,59]. TMs 2, 4, and 6 alternately terminate
translocation, close the translocation pathway, and orient
intracellular loops 1, 2 and the C-terminus into the cytosol
[42]. Thus, as AQP4 TMs are synthesized, the translocation
apparatus (RTC) is regulated such that at any given point of
synthesis, the nascent polypeptide has only one pathway to
follow, either into the ER lumen or into the cytosol (Fig. 3A). In
this manner, the six-spanning topology is established efficiently
and cotranslationally as the polypeptide emerges from the
ribosome. Surprisingly, not all AQPs achieve their topology via
this mechanism.
3.2. AQP1 topogenesis
A detailed analysis of AQP1 revealed that some TMs were
much “less efficient” at controlling the translocation pathway
Fig. 4. Mechanism of AQP1 topological maturation. To acquire its mature six-
spanning topology, TMs 2, 3, and 4 must be reoriented during and/or following
later stages of synthesis. This involves a late 180° rotation of TM3 that converts
it from a type I (Nlum/Ccyto) to a type II (Ncyto/Clum) topology and simultaneously
positions TM2 and TM4 across plane of the membrane. The efficiency of TM3
rotation is increased as TMs 4, 5, and 6 are synthesized. Thus C-terminal folding
information is required for reorienting N-terminal segments. It is currently
unknown whether this unexpected folding step takes place within or adjacent to
the RTC or after complete integration of the polypeptide into the lipid bilayer.
Fig. 3. Different mechanisms of AQP1 and AQP4 topogenesis. (A) AQP4 topogenesis begins as TM1 (blue cylinder) opens the translocon (teal) at the base of the
ribosome (gray disc) and initiates translocation of ECL1 through the translocon pore (left panel). Direction of polypeptide movement is shown by maroon arrow. As
TM2 enters the translocon (middle panel), it terminates translocation and presumably closes the translocon gate via BiP (dark blue bar). Polypeptide movement is then
redirected beneath the base of the ribosome and into the cytosol to establish topology of ICL 1. TM3 exits the ribosome N-terminus first and resets the RTC by opening
the translocation pathway into the lumen thus preventing movement of ECL 2 into the cytosol. During this process, TM3 must rotate 180° such that its N-terminus
(designated by *) remains facing the base of the ribosome and its C-terminus flanking residues are translocated. In this manner, AQP4 TMs are cotranslationally oriented
via the alternatingmovement of peptide loops into the ER lumen and the cytosol [42]. (B) DuringAQP1 biogenesis, translocation is also initiated by TM1.However, TM
2 is unable to terminate translocation and transiently passes through the translocon pore together with ICL1. TM3 enters the translocon, terminates translocation, and
misdirects ECL2 beneath the ribosome into the cytosol. These events result in TM3 inserting N-terminus first into the translocon and adopting an initial type I topology.
Gating of the translocon pore (by BiP) and ribosome–translocon junction are depicted schematically, although the actual mechanisms remain poorly understood.
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does not efficiently terminate translocation either in its native
context or in heterologous chimeric proteins [26,59,60]. As a
result, TM2 passes through the translocon and ICL1 transiently
enters the ER lumen in >50% of nascent polypeptides. Because
TM2 does not close the translocation pathway, TM3 enters an
open translocon. Rather than initiating translocation of ECL2,
TM3 terminates translocation and initially adopts a type I
topology whereby the extracellular loop 2 is mislocalized to the
cytosolic face of the ER membrane [26] (Fig. 3B). This
unorthodox behavior results in a mixture of nascent chain
topologies in which most of the newly synthesized AQP1
molecules initially adopt a four-spanning topology, while only a
minority of chains is cotranslationally directed into the six-
spanning orientation [26,60]. When first reported, these results
caused significant confusion and consternation, as it was
difficult to reconcile the initial cotranslationally established
AQP1 topology in the ER membrane with the mature, six-
spanning topology observed at the plasma membrane [25].
However, subsequent studies using C-terminal translocation
reporters as well as inserted epitope tags have demonstrated that
the four-spanning topology is actually a folding intermediate
that subsequently matures into the six-spanning structure [62].
This is accomplished by an internal 180° rotation of TM3 that
converts TM3 from a type I (Nlum/Ccyto) to a type II (Ncyto/Clum)
topology and brings TM2 and TM4 into the plane of the
membrane (Fig. 4).
Because of the vectoral nature of translation, the N-termini
of internal signal anchor sequences (TM3 and TM5) in AQP1and AQP4 first contact the cytosolic face of the translocon as
they emerge from the ribosome (Fig. 3). In the case of AQP4,
TM3 cotranslationally acquires its type II (Ncyto/Clum)
topology such that its N-terminus remains on the cytosolic
face of the membrane and its C-terminal flanking residues are
directed into the ER lumen (Fig. 3A). Thus, AQP4-TM3 also
undergoes a 180° rotation (from downward to upward
pointing, see Fig. 3A) relative to the direction of polypeptide
movement and its alignment within the ribosome/translocation
pathway. A key difference between AQP1 and AQP4
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of this inversion event. AQP4-TM3 functions efficiently as an
independent type II signal anchor sequence such that
orientation occurs cotranslationally and does not require
synthesis of downstream TM segments [42,59,63]. In
contrast, rotation of AQP1-TM3 occurs at a much later
stage of biogenesis and is highly dependent on the synthesis
of TMs 4–6 [60,62]. For most signal anchor sequences, TM
orientation is rapidly established within the translocon [64]
based on the distribution of flanking charged residues
(positive-in-rule [65–67]), TM length and hydrophobicity
[68], and the folding rate of flanking domains [69]. Analysis
of AQP1 and AQP4 chimeras, however, has indicated that
primary differences in TM3 translocation activity are caused
by variations in C-terminal flanking residues (ECL2) that do
not significantly affect these established parameters [59].
Instead, the data indicate that residues within the C-terminal
half of AQP1 are primarily needed to properly orient N-
terminal TM segments [62,63].
Recent experiments have verified that initial AQP trans-
location events are similar in cell-free, Xenopus oocyte and
mammalian cell expression systems, indicating that the
unexpected AQP1 folding pathway is widely conserved [60].
There are, however, two caveats to these findings. AQP1
topological maturation in vitro (i.e., conversion from a four- to a
six-spanning topology) is dependent upon the source of ER.
AQP1 remains in its immature four-spanning topology when
translated in traditional canine rough ER microsomes but
acquires its mature topology when incorporated into Xenopus
oocyte-derived ER membranes [62]. At present, the specific ER
factors required for AQP1 maturation remain unknown.
Second, truncated AQP1 constructs (lacking TMs 4–6) become
trapped in the immature topology and are relatively unstable.
Thus, immature topological isoforms generated from truncated
proteins can only be observed in mammalian cells when
examined at very short time intervals after synthesis [60,61].
4. General implications of AQP topogenesis
Studies of AQP topogenesis have several significant
implications. First, they demonstrate that translocon gating is
not necessarily absolute. Certain TMs that lack strong topogenic
properties can direct the translocon into alternate conformations
whereby the nascent chain can gain access to either (or both) the
cytosolic and lumenal compartments as it exits the ribosome.
This contrasts with translocation of most secretory and simple
membrane proteins in which signal sequences efficiently direct
a uniform topology by establishing a continuous cytosolically
inaccessible translocation pathway that extends from the
ribosome exit tunnel through the translocon pore [51,52]. It is
currently unknown whether a given translocon can provide
access to both compartments simultaneously, or whether access
is provided in a stochastic manner by adoption of alternate
conformations. We favor the latter explanation at this juncture
because a translocon open to both ER and cytosol could result in
significant mixing of lumenal and cytosolic contents. However,
further work is needed to resolve this question.Second, AQP1 biogenesis has revealed that a mechanism
must exist for reorienting TMs and peptide loops that are
initially directed into the wrong compartment (Fig. 4). Such a
mechanism must provide sufficient flexibility during early
stages of biogenesis to allow for “topological editing” while
downstream TMs are still being synthesized. Although the
mechanism that drives TM3 reorientation remains unknown, it
is interesting that this phenomenon is not restricted to AQP1 but
has also been observed for other native and engineered
eukaryotic polytopic proteins [70–72]. Particularly intriguing,
in this respect, are findings that two bacterial transport proteins,
lactose permease and phenylalanine permease, can exhibit
different topologies depending upon membrane phospholipid
composition [73,74]. Both proteins require phosphatidyletha-
nolamine (PE) for function and undergo a reversible topological
reorientation of several TM segments and connecting loops
when PE is supplied after synthesis has been completed. Thus,
the unexpected folding pathway observed for AQP1 may be a
relatively common feature of diverse membrane proteins that
could be influenced by both the protein machinery and lipid
composition of the cell.
Third, a detailed analysis of AQP1 and AQP4 chimeras has
demonstrated that the topogenic properties can be dramatically
altered by relatively small changes in primary sequence. For
example, two residues at the N-terminus of TM2 (N49 and K51
in AQP1 versus M48 and L50 in AQP4) are responsible for the
different topological behaviors and cotranslational topologies
observed for TM2. Interestingly, N49 and K51 also play a
critical role in generating functional AQP1 water channels [59].
Understanding the role of these residues in AQP function may
explain why two highly homologous proteins utilize such
different folding pathways.
5. Molecular mechanism of membrane integration
Another fundamental requirement for AQP biogenesis is that
each TM segment must be integrated into the lipid bilayer.
Because polypeptide translocation normally occurs through an
aqueous pore, a natural question is whether TM segments
actually translocate into the pore and if so, how and when are
they transferred into lipid. This point has major implications
since early interactions between nascent TM helices (i.e.,
packing and tertiary structure formation) are profoundly
impacted by both general properties of the lipid bilayer as well
as interactions with specific lipids [15,75–77].
5.1. Competing models of lateral translocon gating
Two current and somewhat competing models provide a
mechanistic explanation as to how integration of a simple,
single TM might occur. Both stipulate that in addition to
controlling access into aqueous compartments (e.g., lumen and
cytosol), the translocon also controls lateral access of the
polypeptide into the bilayer. One model proposes that TM
segments passively partition into the bilayer based on their
affinity for the hydrophobic lipid environment [78] (Fig. 5A).
This is consistent with the recent crystal structure of SecYEβ
Fig. 5. Alternate models of TM segment integration. (A) In the sequential integration model, TMs (colored cylinders) enter the translocon (blue disc) and rapidly and
independently pass through a lateral gate where they equilibrate with the lipid bilayer. Packing of helices and tertiary structure formation would thus take place entirely
within the ER membrane. (B) An alternate model is based on evidence that TMs reside within the translocon for prolonged periods of time prior to integration. This
model has significant implications for polytopic proteins because early TM interactions and folding events could be impacted by the physical properties of translocon
proteins and associated lipids. This latter model predicts that the translocon may provide a unique and more permissive folding environment that enables nascent TMs
to sample alternate conformations prior to adapting their final transmembrane structure.
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potentially open laterally between the second and seventh TMs
of Sec61α by a rearrangement of helices [33,79]. Hydrophobic
TM segments could therefore passively move through this
lateral opening into the bilayer based on favorable thermo-
dynamic interactions with membrane lipids [77,78]. An
alternate model proposes that TM segment integration occurs
in a stepwise fashion that is mechanistically controlled and
coordinated by the RTC [27,80,81]. In this latter model, TMs
pass through and reside within distinct molecular environ-
ments within the fully assembled translocon for extended
periods of time (Fig. 5B). Release into the bilayer is triggered
at specific stages of synthesis and/or at the termination of
translation, presumably by conformational changes within the
RTC that push out the previous TM [27]. While both models
agree that TM segments enter the axial translocon pore and
pass laterally into the membrane, the details and mechanism
of this lateral movement remain to be reconciled.
6. Integration intermediates define the nascent chain
environment
Much current knowledge regarding membrane integration
has been derived from biochemical studies of programmed
translocation intermediates. When the ribosome reaches the
end of a truncated mRNA that lacks an endogenous stop
codon, translation ceases, but the polypeptide remains
covalently attached to tRNA within the 80S ribosome. Thus,
by translating mRNAs truncated at different regions in the
coding sequence, it is possible to create synchronized andstable cohorts of nascent chains that reflect the spatial
relationships with respect to the RTC at precise stages of
synthesis [27]. Early studies examining nascent chain–lipid
interactions using alkaline, high salt and urea extraction
confirmed that initial stages of translocation were protein
mediated and could be temporally dissociated from membrane
integration [26,82–86]. In other words, some TM segments
including those in AQP1 can achieve a transmembrane
orientation without fully integrating into the bilayer. These
findings raise questions as to whether TMs might remain
within the translocon prior to integration and if so, where this
might occur.
6.1. Crosslinking approaches
Bifunctional chemical crosslinking agents and incorporated
photoactive probes have begun to provide a more precise view
of the timing and mechanism of integration by identifying
proteins (and lipids) in the immediate vicinity of the nascent
polypeptide. Bifunctional agents typically form covalent bonds
between lysine or cysteine residues on adjacent proteins and
exhibit relatively high crosslinking efficiencies. However,
because they require the close proximity of specific reactive
side chains, they do not necessarily identify nearest neighbors if
the reactive group is beyond the reach of the spacer arm. They
also often generate unwanted secondary and tertiary cross-links
between multiple proteins in large complexes. Alternatively,
photoactive probes such as 5-azido-2-nitrobenzoyl-lys (ANB-
lys) and trifluoromethyl-diazirino-benzoyl-phe (TDB-phe) are
introduced during translation at a unique codon that is
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translation, UV irradiation generates highly reactive radicals
that form nonspecific covalent bonds to neighboring molecules.
Because nascent chains contain a single photoactive probe, only
one crosslink can be formed per polypeptide, and the efficiency
of crosslinking directly reflects the proximity of the probe to the
target protein. By varying the site of probe incorporation and
mRNA truncation, it is thus possible to assess the immediate
environment of the polypeptide at virtually any location within
the translocation pathway of a fully assembled and functional
RTC. This technique provides a non-biased sampling of the
nascent polypeptide environment with sufficient resolution to
identify components adjacent to different regions (e.g., N-
versus C-terminus) as well as different faces of TM helices.
Because the reactive radical species have very short half-lives
and are prone to solvent quenching, photo-crosslinking yields
are generally lower than with bifunctional reagents.
Photo-crosslinking studies have confirmed that secretory
proteins contact Sec61α as they pass through the pore, and that
crosslinking to Sec61α is lost upon entry into the ER lumen
[49,50]. Crosslinking to TMs in bitopic proteins followed
several different patterns [47,78,80]. Some TM segments
containing TDB-phe were found to crosslink phospholipids
almost immediately after contacting Sec61, and lipid cross-
linking was stimulated by increasing TM segment hydropho-
bicity [78,88]. This led to the proposal the TM rapidly passes
through the lateral gate into the bilayer. In contrast, other studies
have revealed that TMs can remain adjacent to Sec61α and
other translocon components during the synthesis of relatively
large cytosolic domains (Fig. 5B) [80,81]. These persistent TM
interactions exhibit distinct asymmetry wherein residues on
different faces of the helix reside in a stable and fixed
orientation with respect to specific translocon components. It
is difficult to generalize from these studies because few TMs
have been examined in detail and because TDB and ANB may
have different propensity for lipid crosslinking [81]. However, it
would appear from the data that not all TMs proceed directly
into the lipid bilayer by a simple partitioning mechanism, and
that the translocon contain specific binding sites [89,90] that
may transiently accommodate TMs during relatively prolonged
periods of polypeptide synthesis.
7. Integration of polytopic proteins
To date few studies have examined how the translocon
synchronizes the sequential integration of multiple TMs as they
rapidly emerge from the ribosome during polytopic protein
synthesis [91–94]. This is particularly important for native
proteins such as aquaporins because TMs must not only
integrate into the membrane but must also acquire tertiary
structure within the lipid bilayer. The early environment
experienced by TMs will therefore play a major role in
determining how and when helices begin to associate [77]. If
TMs disengage from the translocon immediately as they are
synthesized, then helical packing would be driven primarily by
the physical environment of the lipid bilayer as has been
proposed by the two-step model of Popot and Engelman [95]. If,on the other hand, TMs exhibit prolonged interactions with
translocon components, then the proteinaceous environment
imposed by the translocon could significantly influence the rate
and sequence of helical packing and hence the overall folding
pathway. Thus, understanding how the translocon controls the
early environment of TMs is of more than academic interest and
has major implications for diseases in which folding is
perturbed by inherited mutations.
7.1. Photo-crosslinking to AQP4 integration intermediates
To investigate this question, we recently performed a
systematic analysis of interactions between all six AQP4 TMs
and Sec61α during the entire process of synthesis and
integration into the ER membrane [94]. The molecular
environment of the nascent polypeptide was assessed by
examining a comprehensive series of sequentially truncated
AQP4 integration intermediates each of which contained a
single photoactive crosslinking probe (ANB-lys) at one of
three adjacent residues near the center of each TM. The
position of probes within the translocation pathway (i.e.,
distance from the ribosome peptidyltransferase center) was
controlled by varying the site of mRNA truncation, and three
consecutive probe sites per TM were evaluated to determine
the proximity of Sec61α to different faces of the helix. A key
element of this analysis was that each truncation site represents
a single point of synthesis and thus defines the spatial
organization of the nascent polypeptide within the RTC at a
single point in time. Crosslinking profiles of Sec61α
photoadducts at 18 probe incorporation sites in a total of 204
synchronized integration intermediates thus enabled us to
reconstruct dynamic changes experienced by AQP4 TM
helices and to develop the first comprehensive description of
how TMs enter, traverse, and exit the translocon during
synthesis of an entire native polytopic protein (Fig. 6).
Several key findings emerge from this study that bear on
both AQP integration and the general role of the translocon in
the folding process. First, crosslinking patterns to Sec61α
revealed a remarkable coordination of TM entry into,
progression through, and exit from the translocon. Each TM
moved through the translocon in a unique and highly ordered
manner, exhibiting distinct transitions in its relationship to
Sec61α that were tightly coupled to the stage of synthesis. As
TMs contacted the translocon, they quickly acquired a fixed
orientation relative to Sec61α and remained in this “binding”
site only until the oriented entry of the next TM. This suggests
that the translocon utilizes a specific primary entry site within
Sec61α, and that exit from this site is mechanistically coupled
to entry of the next TM. Surprisingly, progression of TMs
through the translocon was remarkably variable. Some TMs,
such as TM2 and TM4, exhibited a single, well-defined period
of crosslinking and then abruptly left the proximity of Sec61α.
TM2 exhibited robust Sec61α crosslinking during synthesis of
only 30 residues while the nascent chain size increased from
110 to 140 residues. Other TMs (e.g., TM1 and TM3) exhibited
several distinct phases of crosslinking in which the helix moved
sequentially into different molecular environments as
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linking to different residues around the helix. The most
remarkable pattern was observed for TM1 which crosslinked
to Sec61α at chain lengths of 80–100, 110–140 and again at a
length of 210 residues (Fig. 6).
7.2. Implication for translocon structure and function
During AQP4 biogenesis, multiple TMs were found to reside
within and/or adjacent to the translocon for relatively prolonged
periods of time. Indeed, at chain lengths of 140 and 210 residues,
crosslinking was simultaneously observed for TMs 1–3, and
TMs 1, 3, 4, and 5, respectively. While we do not yet know the
precise location of each TM relative to all translocon
components, these findings raise important questions regarding
translocon architecture and function during AQP biogenesis. If
translocation takes place through the small pore formed by a
single Sec61 heterotrimer, then secondary sites of contact must
be located outside the pore. Moreover, if Sec61 molecules are
arranged in a back-to-back configuration as has been proposed
[79,96], then TMs would exit laterally away from the translocon
center and towards the lipid bilayer (Fig. 7A). Given the short
length of AQP4 connecting loops and the proposed ∼80 Å
distance between lateral Sec61 exit sites, this configuration
would also require that only one Sec61 complex could be used
for the entire synthesis and integration process [79]. Although
lipid crosslinking was not detected in our study for technical
reasons, this configuration would further suggest that secondary
sites of AQP4 interaction take place at the translocon periphery.
Alternatively, a recent structural model of two E. coli SecYEG
complexes docked onto a translating ribosome has suggested a
front-to-front arrangement [97]. Although an exit pathway was
apparent from only one SecYEG pore, this configuration
positions exit sites adjacent to one another such that TMs
would initially exit from SecYEG into the space between the
heterotrimers prior to reaching the lipid bilayer (Fig. 7B). The
proximity of exit sites could also potentially allow multiple
heterotrimers to be used for translocation if sufficiently aligned
with the ribosome exit tunnel.Fig. 6. Sequential triage of AQP4 TMs by Sec61α. Quantitative profile of
Sec61α crosslinking to truncated AQP4 integration intermediates. ANB-lys
photo-crosslinking probes were incorporated into each AQP4 TM segment at
sites indicated (inset) at the upper left of each panel. The X-axis of each panel
represents the location of mRNA truncation and hence the length of the
integration intermediate examined. Stable truncated integration intermediates
were synthesized in vitro, and photoadducts to Sec61α were identified and
quantitated after crosslinking by immunoprecipitation. In each panel, the
amplitude of the curves therefore shows the relative crosslinking intensity (and
hence proximity) of residues on different faces of the TM helix at a specific stage
of synthesis that corresponds to the site of truncation. When viewed in this
manner, it is possible to simultaneously compare the crosslinking profiles and
hence spatial relationship of all six AQP4 TMs during synthesis of the entire
protein. Note that each TM exhibits a unique pattern of Sec61α crosslinking that
reflects its particular pathway through the translocon. Dashed vertical lines show
specific stages of synthesis that represent key transitions in the environment of
TMs and the coordinated timing of TM entry into and exit out of the primary
Sec61 binding site. Note also that multiple TMs were observed to
simultaneously crosslink Sec61α at the same nascent chain length. Figure was
modified from Sadlish et al. (Ref. [94]).Of course fully assembled eukaryotic translocons are more
complex and have most recently been proposed to contain up to
four Sec61 heterotrimers (as well as accessory proteins)
arranged in a large ring-shaped structure [32]. Significant
evidence has also indicated that fully assembled and functional
translocons contain a large aqueous pore which, during
polypeptide translocation, is continuous with the ribosome exit
tunnel [51,52,98–100] (Fig. 7C). If eukaryotic Sec61αβγ were
Fig. 7. Models of the Sec61 lateral exit gate. (A) Back-to-back configuration. Possible arrangement of Sec61αβγ heterotrimers (Sec) based on Cryo-EM structure of
solubilized ER translocons, 2D crystals of E. coli SecYEG, and high resolution of theMethanococcus SecYEβ [32,33,96]. The lateral gate is shown in yellow and is
proposed to reside between TM2 and TM7 of SecY. The size of individual heterotrimers would place exit sites ∼80 Å from one another [79]. Blue circle represents
nascent TM. Approximate size of the translocon (oval) and proposed location of TRAP is indicated. (B) Schematic representation of front-to-front arrangement of
SecYEG dimers bound to a translating ribosome [97]. (C) Model of translocon derived from fluorescence quenching experiments showing a large central pore
surrounded by oligomeric ring of Sec61 and other translocon proteins [27,51–53]. Lateral exit sites are shown between putative translocon subunits. (D) Hypothetical
arrangement of four Sec61 heterotrimers arranged in a front-to-front configuration showing the lateral exit sites of Sec61 heterotrimers oriented towards the center of
the complex where helices could potentially reside prior to passage between subunits into the lipid bilayer.
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could potentially form a ring, and initial exit of AQP4 TM
helices from the putative small translocation pore could take
place towards the center of the translocon complex (Fig. 7D).
Interestingly, this central region was initially visualized as a
large open pore [43,45,101], but subsequent higher resolution
structures of detergent-solubilized translocons have revealed
only a central depression that has been proposed to contain
mainly lipid [31,32,44]. Because the functional status and
subunit composition of purified translocons are unknown, much
remains to be learned regarding the structure of fully assembled
eukaryotic translocons. An intriguing possibility, although
untested at this point, is that TMs might initially exit from
Sec61 into a relatively hydrophobic, lipid-like environment that
is physically and chemically distinct from the membrane bilayer
and surrounded or partially surrounded by translocon proteins
(Fig. 7D).
7.3. Specific challenges for TM orientation and integration
Regardless of the precise arrangement of Sec61 in the
assembled eukaryotic translocon, the persistent, selective, and
asymmetric binding observed for AQP4 TMs provides strong
evidence that helices do not always freely partition and
equilibrate individually into the lipid bilayer. Rather, it would
appear that some AQP4 helices accumulate at secondary and/or
tertiary sites within an environment that is likely comprised of
both protein and lipid components. Given that the rate of protein
synthesis is remarkably slow when compared to secondary and
tertiary structure formation, it is highly likely that early helix-
helix interactions take place within this immediate environment.
If so, then the translocon could impact early steps of membrane
protein folding in unanticipated ways by influencing the
composition and/or physical properties (i.e., strain energies) of
adjacent lipids [77]. It is tempting to speculate that this mightalso provide a productive environment for formation and early
maturation of folding intermediates such as those observed for
AQP1. It will also be quite interesting to determinewhether AQP
half helices in ICL1 and ECL3 insert directly into membrane
lipids or into a protein scaffold formed by other AQP TMs either
within the translocon or after full release into the lipid bilayer.
A second feature of AQP folding that must be considered is
how TMs are properly oriented within the physical confines of
the translocon apparatus. Since the nascent polypeptide exits the
ribosome vectorally in an N-to C-terminal direction, TMs 1, 3,
and 5 must rotate 180° in order to achieve their correct type II
(Ncyto/Clum) topology. For AQP4, this rotation occurs sequen-
tially and does not require cooperative interactions between
multiple TMs [42,59]. Several lines of evidence have also
suggested that TM helices can form very early within the
translocation pathway and even within the ribosome exit tunnel
[102–105]. Our findings are consistent with this and raise the
question as to when and where helix rotation takes place. Both
the ribosome tunnel [106,107] and putative Sec61α trans-
location pore [32] are clearly too small to accommodate
rotation of a 30 Å helix. Interestingly, crosslinking profiles
revealed that TM3 initially contacts the translocon in a
relatively random orientation and then (~10 residues later)
enters into a fixed binding site within Sec61α where it remains
during synthesis of nearly 80 additional residues. Thus, TM3
rotation occurs either before entry into Sec61 or remarkably
late as it transitions into its site of secondary interaction.
Early rotation could conceivably take place at the base of the
ribosome, particularly if the ribosome–membrane junction were
relaxed coincident with TM2 terminating translocation and
initiating movement of ICL 1 into the cytosol [99]. TM3
rotation could be facilitated by electrostatic interactions
between basic residues near its N-terminus and residues within
Sec61α [64,67]. Alternatively, rotation could conceivably take
place in the context of a larger translocon pore or central
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has been demonstrated by fluorescence quenching experiments
[51–53]. In this case, TM3 would reinitiate translocation upon
entry into Sec61α by reestablishing the ribosome–translocon
junction and opening the translocation pathway [99,100,108]. A
third possibility is that TM3 could enter the translocon in a type
I topology as has been suggested for other signal anchor
sequences and then rotate after its exit into its secondary site of
interaction [64,109].
An additional constraint arises with the sequential arrival of
TMs 4 and 5, which are separated by a very short connecting
loop (∼9 residues). Both helices exhibit peak crosslinking at the
same stage of synthesis, i.e., at a nascent chain length of 216
residues. However, they do not insert in a loop-wise fashion
because TM5 must rotate 180° about its axis to initiate
translocation of ECL3. It is difficult to conceive how a single
Sec61 heterotrimer could simultaneously accommodate TM4,
TM5, TM5 rotation, and a strand of ECL3 given the small
confines of a single hourglass shaped pore. Thus, the
observation that TMs 4 and 5 simultaneously crosslink Sec61
supports the presence of a larger structure (possibly a large pore)
that can accommodate and provide conformational flexibility to
relatively large peptide regions. Important questions therefore
remain as to where closely spaced helices reside during the
orientation and integration process.
8. Conclusions
Advances in our understanding of translocon structure and
function, as well as the biogenesis mechanisms of translocon
“substrates”, have led to various models that attempt to explain
translocation across and integration into the ER membrane. At
the same time, studies of secretory, transmembrane, and
polytopic protein biogenesis have provided key information
that must be incorporated into these models. Studies of AQP
biogenesis have revealed novel and unexpected folding path-
ways that begin to explain how AQP characteristic transmem-
brane structure is formed. These studies also have general
implications for both membrane protein folding and mechan-
isms of translocon function. For example, the sequential entry
and exit of AQP4 TMs into a primary binding site is consistent
with a relatively small translocation pore that accommodates
one helix at a time. In contrast, simultaneous association of
multiple helices, the location and timing of helix rotation, and
physical constraints imposed by short connecting loops require
that any model of translocon structure and function must
accomodate specific biogenesis needs of protein substrates.
It is now clear that the translocon is integrally involved in
directing early events of AQP biogenesis. Evidence also
suggests that its role is not solely limited to translocation of
extracellular domains and orientation and integration of TM
helices. Rather, the early stages of secondary and possibly
tertiary folding are likely initiated within the immediate
environment of the translocon prior to release of the entire
polypeptide into the lipid bilayer. A full understanding of how
these folding events are orchestrated is currently far from our
grasp and will undoubtedly require a more precise knowledge ofthe structural organization of assembled and functional
translocons and their specific interactions with the nascent
chain. Solving this complex and perplexing problemwill require
a variety of perspectives and the concerted efforts of individuals
using complementary techniques. Ultimately, both complemen-
tary and conflicting results must be developed into a unified
model that will describe and enable predictions of membrane
protein folding pathways with accuracy similar to or greater than
that now available for soluble proteins. This information will
then facilitate the formidable task of rational therapeutic
intervention in situations where the folding pathway has been
corrupted by disease-related mutations.
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